Response to Dual Crizotinib and Osimertinib Treatment in a Lung Cancer Patient with MET Amplification Detected by Liquid Biopsy Who Acquired Secondary Resistance to EGFR Tyrosine Kinase Inhibition.
作者信息
Deng Lei, Kiedrowski Lesli A, Ravera Elizabeth, Cheng Haiying, Halmos Balazs
机构信息
Department of Medicine, Jacobi Medical Center/Albert Einstein College of Medicine, Bronx, New York.
Guardant Health, Inc., Redwood City, California.
出版信息
J Thorac Oncol. 2018 Sep;13(9):e169-e172. doi: 10.1016/j.jtho.2018.04.007.
PMID:30166014
Abstract
摘要
Zotero 插件